Mastodon

Ampicillin + Sulbactam (Powder) Instructions for Use

ATC Code

J01CR01 (Ampicillin and beta-lactamase inhibitor)

Active Substances

Ampicillin (Rec.INN registered by WHO)

Sulbactam (Rec.INN registered by WHO)

Clinical-Pharmacological Group

Broad-spectrum penicillin antibiotic with a beta-lactamase inhibitor

Pharmacotherapeutic Group

Systemic antibacterial agents; beta-lactam antibacterial agents, penicillins; combinations of penicillins, including combinations with beta-lactamase inhibitors

Pharmacological Action

A combined broad-spectrum antibacterial agent.

Ampicillin is an antibiotic from the group of semi-synthetic penicillins, whose bactericidal action is associated with the inhibition of microorganism cell wall protein synthesis.

Sulbactam is an irreversible beta-lactamase inhibitor; it expands the spectrum of ampicillin activity against resistant strains whose resistance develops under the influence of beta-lactamases; it does not alter the activity of ampicillin against susceptible strains; by binding to some penicillin-binding proteins of bacteria, it exhibits synergism when used simultaneously with beta-lactam antibiotics. It is stable in aqueous solution, has independent antibacterial activity against the Neisseriaceae family and Acinetobacter spp., and is resistant to the action of most plasmid beta-lactamases.

The combination of Ampicillin+Sulbactam exhibits activity against aerobic gram-positive bacteria – Staphylococcus aureus (beta-lactamase-producing and non-producing strains), Staphylococcus epidermidis (beta-lactamase-producing and non-producing strains), Staphylococcus saprophyticus (beta-lactamase-producing and non-producing strains), Streptococcus pyogenes, Streptococcus pneumoniae (including penicillin-resistant strains), Streptococcus spp. of the viridans group, Enterococcus faecalis, Listeria monocytogenes; aerobic gram-negative bacteria – Escherichia coli, Proteus mirabilis, Proteus vulgaris, Klebsiella spp., Neisseria gonorrhoeae (beta-lactamase-producing and non-producing strains), Moraxella catarrhalis (beta-lactamase-producing and non-producing strains), Morganella morganii, Haemophilus influenzae (including ampicillin-resistant strains), Providencia rettgeri, Providencia stuartii; anaerobic microorganisms – Bacteroides spp., including Bacteroides fragilis, Clostridium spp. (except Clostridium difficile), Peptococcus spp., Peptostreptococcus spp.

Resistant: methicillin-resistant Staphylococcus spp., Citrobacter spp., most strains of Enterobacter spp., Pseudomonas aeruginosa, Mycobacterium spp., Clostridium difficile, Chlamydia pneumoniae, Mycoplasma pneumoniae.

Pharmacokinetics

It penetrates into most tissues and body fluids; during inflammation, permeability into the cerebrospinal fluid increases sharply.

After intravenous and intramuscular administration, high concentrations of sulbactam and ampicillin in the blood are achieved.

T1/2 – 1 h (for ampicillin and sulbactam). It is excreted by the kidneys – 70-80%, mainly unchanged, as well as with bile and breast milk.

Sulbactam undergoes almost no metabolic transformations and is excreted by the kidneys, mainly unchanged and only about 25% as metabolites.

Indications

Treatment of infectious and inflammatory diseases caused by susceptible pathogens: respiratory tract infections (including pneumonia, lung abscess, chronic bronchitis, pleural empyema); ENT organ infections (including sinusitis, tonsillitis, otitis media); urinary tract and genital organ infections (pyelonephritis, pyelitis, cystitis, urethritis, prostatitis, endometritis); biliary tract infections (cholecystitis, cholangitis); skin and soft tissue infections (erysipelas, impetigo, secondarily infected dermatoses); gastrointestinal tract infections (dysentery, salmonellosis, salmonella carriage); bone and joint infections; septic endocarditis; meningitis; sepsis; peritonitis; scarlet fever; gonococcal infection.

Prevention of postoperative complications during operations on the abdominal and pelvic organs.

ICD codes

ICD-10 code Indication
A02 Other salmonella infections
A03 Shigellosis
A09 Other and unspecified gastroenteritis and colitis of infectious origin
A38 Scarlet fever
A40 Streptococcal sepsis
A41 Other sepsis
A46 Erysipelas
A54 Gonococcal infection
G00 Bacterial meningitis, not elsewhere classified
H66 Suppurative and unspecified otitis media
I33 Acute and subacute endocarditis
J01 Acute sinusitis
J02 Acute pharyngitis
J03 Acute tonsillitis
J04 Acute laryngitis and tracheitis
J15 Bacterial pneumonia, not elsewhere classified
J20 Acute bronchitis
J31.2 Chronic pharyngitis
J32 Chronic sinusitis
J37 Chronic laryngitis and laryngotracheitis
J42 Unspecified chronic bronchitis
J85 Abscess of lung and mediastinum
J86 Pyothorax (pleural empyema)
K65.0 Acute peritonitis (including abscess)
K81.0 Acute cholecystitis
K81.1 Chronic cholecystitis
K83.0 Cholangitis
L01 Impetigo
L02 Cutaneous abscess, furuncle and carbuncle
L03 Cellulitis
L08.0 Pyoderma
L08.8 Other specified local infections of skin and subcutaneous tissue
L30.3 Infectious dermatitis (infectious eczema)
M00 Pyogenic arthritis
M86 Osteomyelitis
N10 Acute tubulointerstitial nephritis (acute pyelonephritis)
N11 Chronic tubulointerstitial nephritis (chronic pyelonephritis)
N30 Cystitis
N34 Urethritis and urethral syndrome
N37.0 Urethritis in diseases classified elsewhere
N41 Inflammatory diseases of prostate
N70 Salpingitis and oophoritis
N71 Inflammatory disease of uterus, excluding cervix (including endometritis, myometritis, metritis, pyometra, uterine abscess)
N72 Inflammatory disease of cervix uteri (including cervicitis, endocervicitis, exocervicitis)
N73.5 Unspecified female pelvic peritonitis
N74.3 Gonococcal inflammatory diseases of female pelvic organs
T79.3 Posttraumatic wound infection, not elsewhere classified
Z22.1 Carrier of other infectious gastrointestinal diseases
Z29.2 Other prophylactic chemotherapy (administration of antibiotics for prophylactic purposes)
ICD-11 code Indication
1A02 Intestinal infections due to Shigella
1A09.Z Salmonella infection, unspecified
1A40.Z Infectious gastroenteritis or colitis, unspecified
1A7Z Gonococcal infection, unspecified
1B50 Scarlet fever
1B70.0Z Erysipelas, unspecified
1B70.1 Streptococcal cellulitis of the skin
1B70.2 Staphylococcal cellulitis of the skin
1B70.Z Bacterial cellulitis or lymphangitis caused by unspecified bacterium
1B72.0 Bullous impetigo
1B72.1 Nonbullous impetigo
1B72.Z Impetigo, unspecified
1B75.0 Furuncle
1B75.1 Carbuncle
1B75.2 Furunculosis
1B75.3 Pyogenic skin abscess
1B7Y Other specified pyogenic bacterial infections of skin or subcutaneous tissue
1C44 Non-pyogenic bacterial infections of skin
1D01.0Z Bacterial meningitis, unspecified
1G40 Sepsis without septic shock
AA9Z Unspecified suppurative otitis media
BB4Z Acute or subacute endocarditis, unspecified
CA01 Acute rhinosinusitis
CA02.Z Acute pharyngitis, unspecified
CA03.Z Acute tonsillitis, unspecified
CA05 Acute laryngitis or tracheitis
CA09.2 Chronic pharyngitis
CA0A.Z Chronic rhinosinusitis, unspecified
CA0G Chronic laryngitis or laryngotracheitis
CA20.1Z Chronic bronchitis, unspecified
CA40.0Z Bacterial pneumonia, unspecified
CA42.Z Acute bronchitis, unspecified
CA43.Z Abscess of lung or mediastinum, unspecified
CA44 Pyothorax
DC12.0Z Acute cholecystitis, unspecified
DC12.1 Chronic cholecystitis
DC13 Cholangitis
DC50.0 Primary peritonitis
DC50.2 Peritoneal abscess
DC50.Z Peritonitis, unspecified
EA50.3 Staphylococcal scarlet fever
EA88.0Z Infectious dermatitis, unspecified
EB21 Pyoderma gangrenosum
FA1Z Infectious arthropathies, unspecified
FB84.Z Osteomyelitis or osteitis, unspecified
GA01.Z Inflammatory diseases of uterus, except cervix, unspecified
GA05.2 Unspecified pelvic peritonitis in women
GA07.Z Salpingitis and oophoritis, unspecified
GA91.Z Inflammatory and other diseases of prostate, unspecified
GB50 Acute tubulo-interstitial nephritis
GB51 Acute pyelonephritis
GB55.Z Chronic tubulo-interstitial nephritis, unspecified
GB5Z Renal tubulo-interstitial diseases, unspecified
GC00.Z Cystitis, unspecified
GC02.1 Nonspecific urethritis
GC02.Z Urethritis and urethral syndrome, unspecified
NF0A.3 Posttraumatic wound infection, not elsewhere classified
QC05.Y Other specified prophylactic measures
QD01.Z Carriage of intestinal infectious agent, unspecified
1A71 Gonococcal pelviperitonitis
GA05.Z Inflammatory diseases of female pelvic organs, unspecified
GA0Z Inflammatory diseases of female genital tract, unspecified
XA5WW1 Cervix uteri

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Powder

Intramuscularly, intravenously (by drip at a rate of 60-80 drops/min, by stream – slowly, over 3-5 minutes).

Intravenous administration is used for 5-7 days, then, if it is necessary to continue treatment, switch to intramuscular use.

The following are the total doses of ampicillin and sulbactam (in a 2:1 ratio).

For mild infections – 1.5-3 g/day in 2 administrations; for moderate infections – 3-6 g/day in 3-4 administrations; for severe infections – 12 g/day in 3-4 administrations.

For uncomplicated gonorrhea – 1.5 g, once.

For prevention of surgical infections – 1.5-3 g, during anesthesia; then within 24 hours after surgery – at the same dose every 6-8 hours.

For children – in a daily dose of 150 mg/kg (100 mg/kg ampicillin and 50 mg/kg sulbactam); frequency – 3-4 times/day.

For newborns under 1 week of age and premature infants – every 12 hours.

The course of treatment is 5-14 days (can be extended if necessary). After normalization of temperature and disappearance of other pathological symptoms, treatment is continued for another 48 hours.

In chronic renal failure (creatinine clearance less than 30 ml/min), it is necessary to increase the intervals between administrations.

Adverse Reactions

From the digestive system: nausea, vomiting, decreased appetite, diarrhea, increased activity of “liver” transaminases; rarely – pseudomembranous enterocolitis.

From the hematopoietic organs and hemostasis system: anemia, leukopenia, thrombocytopenia.

From the nervous system: drowsiness, malaise, headache.

Laboratory parameters: azotemia, increased urea concentration, hypercreatininemia.

Allergic reactions: urticaria, skin hyperemia, angioedema, rhinitis, conjunctivitis, fever, arthralgia, eosinophilia, in rare cases – anaphylactic shock.

Local reactions: with intramuscular administration – pain at the injection site; with intravenous – phlebitis.

Other: with prolonged treatment – superinfection caused by microorganisms resistant to the drug (candidiasis).

Contraindications

Hypersensitivity to the components of the drug; infectious mononucleosis; lactation period (breastfeeding).

With caution

Hepatic and/or renal failure, pregnancy.

Use in Pregnancy and Lactation

Use with caution during pregnancy. Contraindicated for use during lactation (breastfeeding).

Use in Hepatic Impairment

With caution: hepatic insufficiency.

Use in Renal Impairment

With caution: renal insufficiency.

Pediatric Use

Use is possible according to the dosage regimen.

Special Precautions

In patients with hypersensitivity to penicillins, cross-allergic reactions with cephalosporin antibiotics are possible.

During course treatment, it is necessary to monitor the state of the function of the hematopoietic organs, liver and kidneys.

The development of superinfection due to the growth of microflora insensitive to the drug is possible, which requires an appropriate change in antibacterial therapy.

When treating patients with sepsis, the development of a bacteriolysis reaction (Jarisch-Herxheimer reaction) is possible.

Drug Interactions

Antacids, glucosamine, laxatives, food, aminoglycosides (when taken orally) slow down and reduce absorption.

Ascorbic acid increases absorption.

Bactericidal antibiotics (including aminoglycosides, cephalosporins, cycloserine, vancomycin, rifampicin) – synergism of action; bacteriostatic drugs (macrolides, chloramphenicol, lincosamides, tetracyclines, sulfonamides) – antagonism of action.

Increases the effectiveness of indirect anticoagulants (by suppressing intestinal microflora, reduces the synthesis of vitamin K and the prothrombin index); reduces the effectiveness of oral contraceptives, drugs in the metabolism of which PABA is formed, and ethinyl estradiol (risk of “breakthrough” bleeding).

Diuretics, allopurinol, phenylbutazone, NSAIDs and other drugs that reduce tubular secretion increase the concentration of ampicillin in plasma.

Allopurinol increases the risk of skin rash.

Pharmaceutical incompatibility

With blood products or protein hydrolysates, aminoglycosides.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Rx Only

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

Brand (or Active Substance), Marketing Authorisation Holder, Dosage Form

Marketing Authorization Holder

AlTro, LLC (Russia)

Manufactured By

Reyoung Pharmaceutical, Co., Ltd. (China)

Dosage Forms

Bottle Rx Icon Ampicillin + Sulbactam Powder for solution for intravenous and intramuscular injection 500 mg+250 mg: vial 1, 10 pcs or 50 pcs.
Powder for solution for intravenous and intramuscular injection 1000 mg+500 mg: vial 1, 10 pcs or 50 pcs.

Dosage Form, Packaging, and Composition

Powder for solution for intravenous and intramuscular injection white or almost white with a yellowish tint.

1 vial
Ampicillin (as sodium salt) 500 mg
Sulbactam (as sodium salt) 250 mg

Vials with a capacity of 10 ml (1) – cardboard packs.
Vials with a capacity of 10 ml (10) – plastic contour packages (trays) (1) – cardboard packs.
Vials with a capacity of 10 ml (50) – plastic contour packages (trays) (1) – cardboard packs.


Powder for solution for intravenous and intramuscular injection white or almost white with a yellowish tint.

1 vial
Ampicillin (as sodium salt) 1000 mg
Sulbactam (as sodium salt) 500 mg

Vials with a capacity of 20 ml (1) – cardboard packs.
Vials with a capacity of 20 ml (10) – plastic contour packages (trays) (1) – cardboard packs.
Vials with a capacity of 20 ml (50) – plastic contour packages (trays) (1) – cardboard packs.

Marketing Authorization Holder

Jodas Expoim, LLC (Russia)

Manufactured By

Jodas Expoim, Pvt. Ltd. (India)

Or

Interpharma, LLC (Russia)

Dosage Forms

Bottle Rx Icon Ampicillin + Sulbactam Powder for solution for intravenous and intramuscular administration 1 g+500 mg: vial. 1 pc.
Powder for solution for intravenous and intramuscular administration 2 g+1 g: fl. 1 pc.
Powder for solution for intravenous and intramuscular administration 250 mg+125 mg: vial 1 pc.
Powder for solution for intravenous and intramuscular administration 500 mg+250 mg: vial. 1 pc.

Dosage Form, Packaging, and Composition

Powder for solution for intravenous and intramuscular administration white or white with a yellowish tint.

1 vial
Ampicillin sodium 1062.9 mg,
   Equivalent to ampicillin content 1000 mg
Sulbactam sodium 547.2 mg,
   Equivalent to sulbactam content 500 mg

Colorless glass vials (1) – cardboard packs.
Colorless glass vials (1) with solvent (water for injection – Registration Certificate No. LP-002377 dated 18.02.2014; amp. 5 ml or 10 ml 1 pc.) – cardboard packs.


Powder for solution for intravenous and intramuscular administration white or white with a yellowish tint.

1 vial
Ampicillin sodium 2125.8 mg,
   Equivalent to ampicillin content 2000 mg
Sulbactam sodium 1094.4 mg,
   Equivalent to sulbactam content 1000 mg

Colorless glass vials (1) – cardboard packs.
Colorless glass vials (1) with solvent (water for injection – Registration Certificate No. LP-002377 dated 18.02.2014; amp. 5 ml or 10 ml 1 pc.) – cardboard packs.


Powder for solution for intravenous and intramuscular administration white or white with a yellowish tint.

1 vial
Ampicillin sodium 265.7 mg,
   Equivalent to ampicillin content 250 mg
Sulbactam sodium 136.8 mg,
   Equivalent to sulbactam content 125 mg

Colorless glass vials (1) – cardboard packs.
Colorless glass vials (1) with solvent (water for injection – Registration Certificate No. LP-002377 dated 18.02.2014; amp. 5 ml or 10 ml 1 pc.) – cardboard packs.


Powder for solution for intravenous and intramuscular administration white or white with a yellowish tint.

1 vial
Ampicillin sodium 531.5 mg,
   Equivalent to ampicillin content 500 mg
Sulbactam sodium 273.6 mg,
   Equivalent to sulbactam content 250 mg

Colorless glass vials (1) – cardboard packs.
Colorless glass vials (1) with solvent (water for injection – Registration Certificate No. LP-002377 dated 18.02.2014; amp. 5 ml or 10 ml 1 pc.) – cardboard packs.

Marketing Authorization Holder

Kraspharma, PJSC (Russia)

Dosage Form

Bottle Rx Icon Ampicillin + Sulbactam Powder for solution for intravenous and intramuscular injection 2 g+1 g: vial with or without solvent

Dosage Form, Packaging, and Composition

Powder for solution for intravenous and intramuscular administration white or almost white, hygroscopic.

1 vial
Ampicillin (as sodium salt) 2000 mg
Sulbactam (as sodium salt) 1000 mg

Solvent water for injection in amp.

1 pc. – 5 ml vials (1) – cardboard packs.
1 pc. – 10 ml vials (1) – cardboard packs.
1 pc. – 5 ml vials (1) (1-50 pcs.) – cardboard boxes (for hospitals).
1 pc. – 10 ml vials (1) (1-50 pcs.) – cardboard boxes (for hospitals).
1 pc. – 5 ml vials (1) – cardboard packs (with solvent: 5 ml amp. 2 pcs. and ampoule opener).
1 pc. – 10 ml vials (1) – cardboard packs (with solvent: 10 ml amp. 1 pc. and ampoule opener).
1 pc. – 5 ml vials (5) – cardboard packs (with solvent: 5 ml amp. 10 pcs. and ampoule opener).
1 pc. – 10 ml vials (5) – cardboard packs (with solvent: 10 ml amp. 5 pcs. and ampoule opener).

Marketing Authorization Holder

Kraspharma, PJSC (Russia)

Dosage Form

Bottle Rx Icon Ampicillin + Sulbactam Powder for solution for intravenous and intramuscular injection 500 mg+250 mg: vial 10 pcs.

Dosage Form, Packaging, and Composition

Powder for solution for intravenous and intramuscular administration 1 vial
Ampicillin (as sodium salt) 500 mg
Sulbactam (as sodium salt) 250 mg

Vials (10) – cardboard packs.

Marketing Authorization Holder

Kraspharma, PJSC (Russia)

Dosage Form

Bottle Rx Icon Ampicillin + Sulbactam Powder for solution for intravenous and intramuscular injection 1 g+500 mg: vial 10 pcs.

Dosage Form, Packaging, and Composition

Powder for solution for intravenous and intramuscular administration 1 vial
Ampicillin (as sodium salt) 1 g
Sulbactam (as sodium salt) 500 mg

Vials (10) – cardboard packs.

Marketing Authorization Holder

Promomed Rus LLC (Russia)

Manufactured By

Biokhimik, JSC (Russia)

Dosage Forms

Bottle Rx Icon Ampicillin + Sulbactam Powder for solution for intravenous and intramuscular injection 500 mg+250 mg: vial 1, 5 or 10 pcs.
Powder for solution for intravenous and intramuscular injection 1000 mg+500 mg: vial 1, 5 or 10 pcs.
Powder for solution for intravenous and intramuscular injection 2000 mg+1000 mg: vial 1, 5 or 10 pcs.

Dosage Form, Packaging, and Composition

Powder for solution for intravenous and intramuscular administration white or almost white, crystalline.

1 vial
Ampicillin sodium 531.5 mg,
   Equivalent to ampicillin content 500 mg
Sulbactam sodium 273.6 mg,
   Equivalent to sulbactam content 250 mg

Glass vials (1) – cardboard packs.
Glass vials (5) – cardboard packs.
Glass vials (10) – cardboard packs.
Glass vials (1) with solvent* (amp. 5 ml 1 pc.) – cardboard packs.
Glass vials (5) with solvent* (amp. 5 ml 5 pcs.) – cardboard packs.
Glass vials (10) with solvent* (amp. 5 ml 10 pcs.) – cardboard packs.

Solvent water for injection or 0.5% novocaine solution.


Powder for solution for intravenous and intramuscular administration white or almost white, crystalline.

1 vial
Ampicillin sodium 1062.9 mg,
   Equivalent to ampicillin content 1000 mg
Sulbactam sodium 547.2 mg,
   Equivalent to sulbactam content 500 mg

Glass vials (1) – cardboard packs.
Glass vials (5) – cardboard packs.
Glass vials (10) – cardboard packs.
Glass vials (1) with solvent* (amp. 5 ml 1 pc.) – cardboard packs.
Glass vials (5) with solvent* (amp. 5 ml 5 pcs.) – cardboard packs.
Glass vials (10) with solvent* (amp. 5 ml 10 pcs.) – cardboard packs.

Solvent water for injection or 0.5% novocaine solution.


Powder for solution for intravenous and intramuscular administration white or almost white, crystalline.

1 vial
Ampicillin sodium 2125.8 mg,
   Equivalent to ampicillin content 2000 mg
Sulbactam sodium 1094.4 mg,
   Equivalent to sulbactam content 1000 mg

Glass vials (1) – cardboard packs.
Glass vials (5) – cardboard packs.
Glass vials (10) – cardboard packs.
Glass vials (1) with solvent* (amp. 5 ml 2 pcs.) – cardboard packs.
Glass vials (5) with solvent* (amp. 5 ml 10 pcs.) – cardboard packs.
Glass vials (10) with solvent* (amp. 5 ml 20 pcs.) – cardboard packs.

Solvent water for injection or 0.5% novocaine solution.

Marketing Authorization Holder

Alvils, LLC (Russia)

Manufactured By

Belarusian-Dutch Joint Venture "FARMLAND", LLC (Republic of Belarus)

Dosage Forms

Bottle Rx Icon Ampicillin + Sulbactam-Alvils Powder for solution for intravenous and intramuscular administration 250 mg+125 mg: vial 1, 5, 10 or 50 pcs.
Powder for solution for intravenous and intramuscular administration 500 mg+250 mg: vial 1, 5, 10 or 50 pcs.
Powder for solution for intravenous and intramuscular administration 1000 mg+500 mg: vial 1, 5, 10 or 50 pcs.
Powder for solution for intravenous and intramuscular injection 2000 mg+1000 mg

Dosage Form, Packaging, and Composition

Powder for solution for intravenous and intramuscular administration

1 vial
Ampicillin (as sodium salt) 250 mg
Sulbactam (as sodium salt) 125 mg

375 mg – vials – cardboard packs – Prescription only
375 mg – vials (10 pcs.) – cardboard packs – Prescription only
375 mg – vials (5 pcs.) – cardboard packs – Prescription only


Powder for solution for intravenous and intramuscular administration

1 vial
Ampicillin (as sodium salt) 500 mg
Sulbactam (as sodium salt) 250 mg

750 mg – vials – cardboard packs – Prescription only
750 mg – vials (10 pcs.) – cardboard packs – Prescription only
750 mg – vials (5 pcs.) – cardboard packs – Prescription only


Powder for solution for intravenous and intramuscular administration

1 vial
Ampicillin (as sodium salt) 1000 mg
Sulbactam (as sodium salt) 500 mg

1500 mg – vials – cardboard packs – Prescription only
1500 mg – vials (10 pcs.) – cardboard packs – Prescription only
1500 mg – vials (5 pcs.) – cardboard packs – Prescription only


Powder for solution for intravenous and intramuscular administration

1 vial
Ampicillin (as sodium salt) 2000 mg
Sulbactam (as sodium salt) 1000 mg

3000 mg – vials – cardboard packs – Prescription only
3000 mg – vials (10 pcs.) – cardboard packs – Prescription only
3000 mg – vials (5 pcs.) – cardboard packs – Prescription only

Marketing Authorization Holder

Protek-SVM LLC (Russia)

Manufactured By

Ruzpharma, LLC (Russia)

Dosage Forms

Bottle Rx Icon Ampicillin + Sulbactam-LEKSVM® Powder for solution for intravenous and intramuscular administration 250 mg+125 mg: vial 1, 5, 10 or 50 pcs.
Powder for solution for intravenous and intramuscular administration 500 mg+250 mg: vial 1, 5, 10 or 50 pcs.
Powder for solution for intravenous and intramuscular administration 1000 mg+500 mg: vial 1, 5, 10 or 50 pcs.
Powder for solution for intravenous and intramuscular injection 2000 mg+1000 mg

Dosage Form, Packaging, and Composition

Powder for solution for intravenous and intramuscular administration

1 vial
Ampicillin (as sodium salt) 250 mg
Sulbactam (as sodium salt) 125 mg

375 mg – vials – cardboard packs – Prescription only
375 mg – vials (50 pcs.) – cardboard boxes – for hospitals


Powder for solution for intravenous and intramuscular administration

1 vial
Ampicillin (as sodium salt) 500 mg
Sulbactam (as sodium salt) 250 mg

750 mg – vials – cardboard packs – Prescription only
750 mg – vials (50 pcs.) – cardboard boxes – for hospitals


Powder for solution for intravenous and intramuscular administration

1 vial
Ampicillin (as sodium salt) 1000 mg
Sulbactam (as sodium salt) 500 mg

1500 mg – vials – cardboard packs – Prescription only
1500 mg – vials (50 pcs.) – cardboard boxes – for hospitals


Powder for solution for intravenous and intramuscular administration

1 vial
Ampicillin (as sodium salt) 2000 mg
Sulbactam (as sodium salt) 1000 mg

3000 mg – vials – cardboard packs – Prescription only
3000 mg – vials (50 pcs.) – cardboard boxes – for hospitals

TABLE OF CONTENTS